Effects of acetyl-L-carnitine and methylcobalamin for diabetic peripheral neuropathy: A multicenter, randomized, double-blind, controlled trial
Important: Dont stop a GLP-1 medication or change your dose schedule without medical guidance
e.g., acrylamide) formed by high-temperature industrial frying, which has been suggested to contribute to neuroinflammation and neurotoxicity mediated through the generation of free radicals, mitochondrial dysfunction and activation of glial cells such as BV-2 microglial cells, primary astrocytes, and microglia, together inducing neuronal apoptosis (8, 4850)
If cleared, a Phase 1 Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD) Phase 1 study is expected to begin in Q2 2026, with initial human data likely by late 2026